Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-01-19Clinical Trial Update: Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder [Phase 3]
A Phase 3 trial evaluating ALKS 3831 for body weight effects in young adults recently diagnosed with schizophrenia, schizophreniform disorde…
-
CLINICAL_TRIALS trial_result · 2023-01-18Clinical Trial Update: Circuitry-Guided Smoking Cessation in Schizophrenia [NA]
A completed clinical trial investigating circuitry-guided smoking cessation in individuals with schizophrenia; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-12-30Clinical Trial Update: Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study [NA]
A completed clinical trial evaluating transcranial magnetic stimulation targeting the cerebellum for schizophrenia-related psychosis with re…
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: Restoration of Cognitive Function With TDCS and Training in Serious Mental Illness [NA]
Completed clinical trial investigating transcranial direct current stimulation (TDCS) plus training to restore cognitive function in serious…
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia [Phase 4]
Phase 4 trial update on memantine's effects for sensorimotor gating and neurocognition in schizophrenia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-14Clinical Trial Update: Treatment of Negative Symptoms and Schizophrenia [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial investigating treatment for negative symptoms in schizophrenia conducted by University Hospital, Montpe…
-
CLINICAL_TRIALS trial_result · 2022-12-12Clinical Trial Update: A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia [Phase 4]
A Phase 4 study evaluating agomelatine in combination with antipsychotics for negative symptoms in schizophrenia; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2022-11-22Clinical Trial Update: Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients [Phase 4]
A Phase 4 trial evaluating a fixed-dose intervention to enhance survival in patients with serious mental illness, including schizophrenia an…
-
CLINICAL_TRIALS trial_result · 2022-11-21Clinical Trial Update: Levetiracetam in Early Psychosis [Phase 2]
Phase 2 trial update evaluating levetiracetam in early psychosis has been completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia [Phase 1, Phase 2]
Clinical trial updates report studying pentoxifylline as an adjunctive treatment for negative symptoms in chronic schizophrenia (Phase 1/Pha…
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Group Cognitive-behavioral Intervention for Social Anxiety in Schizophrenia [Phase 1, Phase 2]
This clinical trial update reports on a group cognitive-behavioral intervention for social anxiety in individuals with schizophrenia, coveri…
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: A Study of LY2140023 in Patients With Schizophrenia [Phase 3]
Phase 3 clinical trial update for LY2140023 in schizophrenia; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Families With Substance Use and Psychosis: A Pilot Study [NA]
A completed pilot study from McLean Hospital investigating families with substance use and psychosis; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia [Phase 3]
Phase 3 trial completed evaluating TV-46000 for maintenance treatment in schizophrenia; results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME) [NA]
Completed clinical trial TIME studied targeted self-management for epilepsy and serious mental illness; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial [NA]
Completed randomized trial assessing the impact of physical activity on health outcomes in schizophrenia-spectrum disorders; results posted …
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients [Phase 3]
Phase 3 trial comparing LY2140023 with aripiprazole in schizophrenia was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: Cannabidiol Treatment in Patients With Early Psychosis [Phase 2]
Phase 2 trial of cannabidiol for early psychosis completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy [Phase 4]
A Phase 4 clinical trial update assessing disturbance of plasma cytokine parameters in clozapine-resistant, treatment-refractory schizophren…
-
CLINICAL_TRIALS trial_result · 2022-09-01Clinical Trial Update: A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients [Phase 2]
A Phase 2 safety trial comparing LY2140023 to standard atypical antipsychotic treatment in schizophrenia has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-08-29Clinical Trial Update: Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia [Phase 2, Phase 3]
Phase 2/3 trial investigating alpha-lipoic acid as adjunctive therapy for schizophrenia with a focus on oxidative stress, completed.
-
CLINICAL_TRIALS trial_result · 2022-08-23Clinical Trial Update: Carnosine and Cognitive Training in Schizophrenia [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating the combination of carnosine and cognitive training in schizophrenia has been completed.
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI) [NA]
A completed clinical trial on persistence-targeted smoking cessation in individuals with serious mental illness has posted results as of 202…
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Stimulating the Brain to Improve Self-Awareness [NA]
A completed clinical trial on brain stimulation to improve self-awareness in schizophrenia and schizoaffective disorder, with results posted…
-
CLINICAL_TRIALS trial_result · 2022-07-07Clinical Trial Update: Non-Invasive Direct Current Stimulation for Cognition in Schizophrenia [NA]
A terminated clinical trial investigating non-invasive direct current stimulation for cognition in schizophrenia/psychosis; results posted i…